Covalent adducts of proteins with acetaldehyde in the liver as a result of acetaldehyde administration in drinking water

Journal of Hepatology

Volumn 33, Issue 6, 2000, Pages 926-932

  Jokelainen, Kalle ^a   Parkkila, Seppo ^b   Salaspuro, Mikko ^a,c   Niemelä, Onni ^b,c  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF OULU   (Finland)

^c EP Central Hospital Laboratory   (Finland)

Author keywords

Ethanol metabolism; Immunohistochemistry; Liver disease

Indexed keywords

ACETALDEHYDE; ALCOHOL; DRINKING WATER;

ALCOHOL METABOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CELL KINETICS; CONTROLLED STUDY; HISTOPATHOLOGY; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; KUPFFER CELL; LIVER DISEASE; LIVER TOXICITY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN MODIFICATION; RAT; STELLATE CELL;

EID: 0033646582     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(00)80124-5     Document Type: Article

References (47)

1. Medical disorders of alcoholism
2. Monoclonal and polyclonal antibodies against acetaldehyde-containing epitopes in acetaldehyde-protein adducts
3. Immune responses to acetaldehyde-protein adducts: Role in alcoholic liver disease
4. Immunohistochemical demonstration of acetaldehyde-modified epitopes in human liver after alcohol consumption
5. Acetaldehyde-modified epitopes in liver biopsy specimens of alcoholic and nonalcoholic patients: Localization and association with progression of liver fibrosis
6. Hepatic fibrosis produced in guinea pigs by chronic ethanol administration and immunization with acetaldehyde adducts
7. Sequential acetaldehyde production, lipid peroxidation and fibrogenesis in micropig model of alcohol-induced liver disease
8. Serum low density lipoprorein of alcoholic patients is chemically modified in vivo and induces apolipoprotein E synthesis by macrophages
9. In vitro acetaldehyde formation by human colonic bacteria
10. High intracolonic acetaldehyde values produced by a bacteriocolonic pathway for ethanol oxidation in piglets
11. Bacteriocolonic pathway for ethanol oxidation
12. Hepatotoxicity and absorption of extrahepatic acetaldehyde in rats
13. Bacteriocolonic pathway for ethanol oxidation: Characteristics and implications
14. Increased acetaldehyde production by mouthwashings from patients with oral cavity, laryngeal, or pharyngeal cancer
15. Covalent protein adducts in the liver as a result of ethanol metabolism and lipid peroxidation
16. Covalent binding of acetaldehyde to proteins: Participation of lysine residues
17. Covalent binding of acetaldehyde selectively inhibits the catalytic activity of lysine dependent enzymes
18. Acetaldehyde adducts with proteins: Binding of [(14)C] acetaldehyde to serum albumin
19. Characterization of the increased binding of acetaldehyde to red blood cells in alcoholics
20. Acetaldehyde substoichiometrically inhibits bovine neurotubulin polymerization
21. Acetaldehyde adducts and autoantibodies against VLDL and LDL in alcoholics
22. Formation of acetaldehyde adducts with ethanol-inducible P450IIE1 in vivo
23. Antibodies against acetaldehyde-modified epitopes: An elevated IgA response in alcoholics
24. Serum IgA, IgG, and IgM antibodies directed against acetaldehyde-derived epitopes: Relationship to liver disease severity and alcohol consumption
25. Nucleoside adducts are formed by cooperative reaction of acetaldehyde and alcohols: A possible mechanism for the role of alcohol in carcinogenesis
26. Effects of acetaldehyde on cell regeneration and differentiation of the upper gastrointestinal tract mucosa
27. Role of lipid peroxidation and stress in alcohol toxicity
28. Acetaldehyde selectively stimulates collagen production in cultured rat liver fat-storing cells but not in hepatocytes
29. Acetaldehyde activates the promoter of the mouse α2(I) collagen gene
30. Effect of ethanol on cytochrome P450 (CYP2E1), lipid peroxidation and serum protein adduct formation in relation to liver pathology pathogenesis
31. Early alcoholic liver injury formation of protein adducts with acetaldehyde and lipid peroxidation products, and expression of CYP2E1 and CYP3A
32. High-level expression of rat class I alcohol dehydrogenase is sufficient for ethanol-induced fat accumulation in transduced HeLa cells
33. Hepatic stellate cell activation occurs in the absence of hepatitis in alcoholic liver disease and correlates with the severity of steatosis
34. Acetaldehyde prevents nuclear factor-kappa B activation and hepatic inflammation in ethanol-fed rats
35. Acetaldehyde-modified and 4-hydroxynonenal-modified proteins in the livers of rats with alcoholic liver disease
36. Histochemical and immunohistochemical evidence for hepatic zone 3 distribution of alcohol dehydrogenase in rats
37. The intralobular distribution of ethanol inducible P450IIE1 in rat and human liver
38. Review by an International Group. Alcoholic liver disease: Morphological manifestations
39. Inhibition of intracolonic acetaldehyde production and alcoholic fermentation in rats by ciprofloxacin
40. The structure and function of human IgA
41. Localization of protein-acetaldehyde adducts on cell surface of hepatocytes by flow cytometry
42. Long-term ethanol administration alters the degradation of acetaldehyde adducts by liver endothelial cells
43. Binding of antiacetaldehyde IgG antibodies to hepatocytes with an acetaldehyde-phosphatidylethanolamine adduct on their surface
44. Cellular and subcellular localization of acetaldehyde-protein adducts in liver biopsies from alcoholic patients
45. High blood alcohol levels in women. The role of decreased gastric alcohol dehydrogenase activity and first pass metabolism
46. Binding of acetaldehyde to rat gastric mucosa during ethanol oxidation
47. Ethanol metabolism in the gastrointestinal tract and its possible consequences